Yuhan Corp (Yuhan) researches, develops, manufactures and markets dental supplies, medical devices, prescription drugs, veterinary medicines, quasi-drugs, healthcare products, over the counter products and other household consumer goods in domestic and international market. It develops new chemical entities, market-oriented IMDs (Incrementally modified drugs) and APIs/intermediates for overseas markets.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Yuhan focuses on the R&D to develop new drugs for its customers. The company conducts its R&D activities in six laboratories, namely, drug discovery, biotech, pharmaceutical development, process development, drug evaluation and pharmaceutical analysis. The company has selected cancer, metabolism, and the central nervous system as its three first-tier priority areas for R&D focus. The Yuhan Research Institute is the hub of R&D activities of the company which focuses on the development of market-oriented new pharmaceutical products to target the future market and pharmaceutical ingredients for the global customers. It is also advancing research programs to develop a new product pipeline consisting of anti-diabetic agents, next generation anti-ulcer cures and new biotech products. The Yuhan Research Institute is situated at Giheung in Yongin City, Korea. In FY2024, the company spent KRW206,947.2 million on its R&D activities, which as a percentage of revenue stood at 10% and grew 82.4% YoY.